■这项研究的目的是探讨肥胖对库欣综合征患者腹腔镜肾上腺手术结果的影响。
■这项回顾性研究于2010年1月至2023年1月在Erciyes大学医学院普通外科进行。我们的分析包括库欣综合征患者,这些患者接受了经腹外侧入路的单侧腹腔镜肾上腺切除术(LA)。对所有患者进行年龄评估,性别,肿瘤直径,体重指数(BMI),美国麻醉医师协会身体状况分类,发病率,手术史,肿瘤侧,手术时间,转换为开放手术,并发症,和住院时间。
■共有90名患者(75名女性和15名男性)接受了经腹膜LA。根据BMI将患者分为2组:肥胖组(≥30kg/m2;n=53,58.8%)和非肥胖组(<30kg/m2;n=37,41.2%)。将所有患者分为3个亚组:肥胖患者组,BMI≥30-39kg/m2(n=23);病态肥胖患者组,BMI≥40kg/m2(n=14);非肥胖患者组,BMI<30kg/m2(n=53)。术中并发症无显著差异,转换为开放手术,手术时间,或两组之间的住院时间。在单变量和多变量分析中,仅转换为开放手术是术后并发症的危险因素(比值比,15.4;95%置信区间,1.277-185.599;P=0.031)。
■我们的结果表明,LA对病态肥胖的库欣综合征患者是安全有效的,允许可接受的发病率和住院时间。
UNASSIGNED: The aim of this study is to investigate the effect of obesity on the results of laparoscopic adrenal surgery in patients with Cushing syndrome.
UNASSIGNED: This retrospective study was performed in Department of General Surgery at Erciyes University School of Medicine between January 2010 and January 2023. Our analysis included Cushing syndrome patients who underwent unilateral laparoscopic adrenalectomy (LA) with the transabdominal lateral approach. All patients were evaluated in terms of age, sex, tumor diameter, body mass index (BMI), American Society of Anesthesiologists physical status classification, morbidities, surgery history, tumor side, operative time, conversion to open surgery, complications, and length of hospital stay.
UNASSIGNED: A total of 90 patients (75 females and 15 males) underwent a transperitoneal LA. Patients were divided into 2 groups according to their BMI: obese group (≥30 kg/m2; n = 53, 58.8%) and nonobese group (<30 kg/m2; n = 37, 41.2%). All patients were classified into 3 subgroups: obese patient group, BMI ≥30-39 kg/m2 (n = 23); morbidly obese patient group, BMI ≥40 kg/m2 (n = 14); and nonobese patient group, BMI <30 kg/m2 (n = 53). There was no significant difference in intraoperative complications, conversion to open surgery, operative time, or length of hospital stay between the groups. Only conversion to open surgery was a risk factor for postoperative complications in univariate and multivariate analyses (odds ratio, 15.4; 95% confidence interval, 1.277-185.599; P = 0.031).
UNASSIGNED: Our results showed that LA is safe and effective in patients with Cushing syndrome with morbid obesity, allowing acceptable morbidity and length of hospital stay.